London

Millbank Tower
21-24 Millbank
London SW1 4QP
UK

For all London enquiries

New York

The Genome Center
101 6th Avenue
New York NY 10013
USA

For all New York enquiries

Shanghai

Room 123, 13th Floor,
Shanghai Tower,
No. 501 Yincheng Middle Road, China

For all Shanghai enquiries

© 2020 Huma. All rights reserved.

News

Huma making the news

featured

The Telegraph

Medopad rebrands and acquires two tech companies to bolster remote monitoring of patients

16 Apr 2020
featured

Forbes

Medopad rebrands to Huma and announces the acquisition of two healthtech companies

16 Apr 2020
featured

Huma

Medopad rebrands as Huma as it expands offerings and acquires AI and wearable tech startups

16 Apr 2020
featured

NewStatesman

How your smartphone can help with COVID-19

3 Apr 2020
innovation

The Economist

Digital Biomarkers and how it will change the future of healthcare

16 Mar 2020
featured

The Telegraph

British health-tech company raises $25 million.

5 Nov 2019
innovation

Forbes

Medopad and Janssen develop digital test to detect and quantify Alzheimer's Disase progression.

5 Nov 2019
innovation

China Daily

Medopad and Tencent grows relationship beyond Parkinson's Disease.

8 May 2019
innovation

Financial Times

Medopad and Tencent expands partnership to develop cutting edge AI and predictive capabilities for Psoriasis, MS, Cardiovascular disease and more.

6 May 2019
featured

CB Insights

Medopad on CB Insights AI 100 list.

6 Feb 2019
featured

The Journal of mHealth

Medopad ranks on Global Digital Health 100.

30 Jan 2019
featured

BBC

Advances in artificial intelligence prompt a revolution in how we access healthcare.

9 Jan 2019
featured

Digital Health

Medopad aims to help one billion patients live longer.

20 Nov 2018
innovation

Bloomberg

Tencent looks to London healthtech startup to partner with on Parkinson’s AI

8 Oct 2018
innovation

BBC

Chinese tech giant Tencent has partnered with a London firm to help Parkinson's patients.

8 Oct 2018
featured

LinkedIn

LinkedIn rates Medopad as one of the 25 most sought after startups to work for in the UK

30 Sep 2018
featured

CNBC

Medopad signs partnership with Tencent

17 Sep 2018
featured

Business Insider UK

Medopad acquires patient-tracking rival Sherbit to expand to US and boost AI capabilities.

11 Sep 2018
featured

The Telegraph

Medopad bolsters its US presence

3 Jul 2018
featured

The National

Medopad signs deals with Saudi Arabia following Crown Prince’s visit to the UK

16 May 2018
featured

Crunch Base

Medopad features as one of the top 9 startups that are shaping the future of health

2 May 2018
featured

South China Morning Post

China to test data monitoring system for hospital outpatients under trial scheme this year

22 Apr 2018
featured

CNBC

BOAO Conference 2018: How technology can keep patients with chronic conditions away from hospitals

10 Apr 2018
featured

Imperial College Health Partners

Medopad agrees partnership with Imperial College Health Partners

22 Feb 2018
featured

Financial Times

The rise of consumer healthcare

16 Feb 2018
featured

Business Insider

Healthtech startup without VC funding lands $140 in Chinese deals and partnership with Tencent

14 Feb 2018
featured

Forbes

UK Healthtech startup works with China to improve it’s AI

6 Feb 2018
featured

UKTN

Medopad raises $28m at the first close of its Series A round

2 Feb 2018
featured

The Telegraph

Medopad planning a $120m fund raise following China deal

2 Feb 2018
featured

Bloomberg

UK Healthtech startup backed by the likes of Bayer raises funds with UBS

16 Aug 2017
innovation

Apple

Tim Cook, CEO of Apple, references Medopad’s Aple Watch patient monitoring app and work with London King’s College Hospital in his Q3 earnings

1 Aug 2017
featured

KPMG

KPMG names Medopad a $1 billion HealthTech company in the making

16 Feb 2016

Medopad is now Huma. Huma has acquired Biobeats and TLT.

cross

By clicking "Accept", you agree to the storing of cookies on your device to enhance site
navigation, analyse site usage, and assist in our marketing efforts. Read our Cookie Policy.

Accept Decline
cross